Clinical trial
Cell Lines From High-Risk Breast Tissue
NCT00032201 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00032201 |
|---|---|
| Title | Cell Lines From High-Risk Breast Tissue |
| Official title | Establishment of Normal High Risk Breast Epithelial Cell Cultures, and A High Risk Cell Line and Tissue Repository From Breast Tissue From Women at High Risk of Breast Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Healthy |
| Enrollment | 43 |
| Start date | Mar 6, 2002 |
| Completion | Dec 3, 2014 |
| First posted | Mar 11, 2002 |
| Last update posted | Dec 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: